Preclinical pharmacokinetic/pharmacodynamic (PK/PD) relationship of ABN401, a highly selective met inhibitor, in gastric and non-small cell lung cancer models
J. Kim, Y. Kim, K. Park, Yonghwan Jeong, Jae‐Kap Choi, Suk‐Jae Chung, Y. H. Shin, Sun Woo Hong